Breaking News

Bioline Expands into Singapore

By Kristin Brooks | January 14, 2014

Aims to expand PCR business in the region

Bioline, The PCR Company, a subsidiary of Meridian Bioscience, has opened an office in Singapore to expand the Bioline business locally and throughout Asia. Bioline supplies customers worldwide with polymerase chain reaction (PCR) reagents, and will provide direct sales, technical support, and training to its existing customers and will also offer same-day delivery to some of its Singapore-based customers.
The Singapore office aims to provide a platform for Bioline to expand into these growing markets. The company has added several sales and support positions at Bioline Singapore. The new location will also be key in the future development of opportunities in the region and to support life science researchers within Asia.
Richard L. Eberly, president of Meridian Life Science, added, “We are delighted to open the new Bioline office in Singapore. Our customers can now call us locally, place orders, and receive the goods the same day. This is a further demonstration of our commitment to our life science customers and to bringing innovation and quality products; such as the highly popular SensiFAST Real-Time kits and the proven MyTaq DNA Polymerase to the research laboratory, clinical diagnostic laboratories, and biotechnology companies.”
blog comments powered by Disqus
  • Setting Health-Based Exposure Limits to Support Pharmaceutical Development and Manufacturing

    Setting Health-Based Exposure Limits to Support Pharmaceutical Development and Manufacturing

    B.D. Naumann, P.J. Nigro, U. Bruen, L. Parola, D. Cragin and A. Schatz, Merck & Co., Inc. and Ashland, Inc.||May 5, 2016
    Health-based exposure limits are needed to support risk assessments

  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.